<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd">
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" width="781px" height="3271px" viewBox="-0.5 -0.5 781 3271" content="&lt;mxfile host=&quot;app.diagrams.net&quot; modified=&quot;2020-06-25T23:57:19.312Z&quot; agent=&quot;5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.116 Safari/537.36&quot; etag=&quot;G8AkRYnJ95xM_SfyHmp8&quot; version=&quot;13.3.4&quot; type=&quot;github&quot;&gt;&lt;diagram id=&quot;8JQaeR7ikDl0GVS66GYh&quot; name=&quot;Page-1&quot;&gt;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&lt;/diagram&gt;&lt;/mxfile&gt;" resource="https://app.diagrams.net/?src=about#HMedeler%2Fhtml%2Fmaster%2Fpdf%2Fsvg%2F155_tuberculose.svg"><defs/><g><rect x="20" y="1760" width="760" height="480" fill="none" stroke="#000000" pointer-events="all"/><rect x="20" y="2360" width="758" height="910" fill="none" stroke="#000000" pointer-events="all"/><rect x="428" y="2380" width="350" height="120" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 343px; height: 1px; padding-top: 2387px; margin-left: 435px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Le <b>suivi </b>comprend :</div><div><ul><li>clinique, RXT, bactério jusqu'à négativation</li><li>vision couleurs mensuel pendant ttt EMB</li><li>bilan hépatique</li><ul><li>arrêt PZA si &gt; 3N</li><li>arrêt PZA et INH si &gt; 6N</li></ul></ul></div></div></div></div></foreignObject><text x="435" y="2399" fill="#000000" font-family="Karla" font-size="12px">Le suivi comprend :...</text></switch></g><rect x="98" y="2380" width="330" height="110" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 323px; height: 1px; padding-top: 2387px; margin-left: 105px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Le bilan <b>pré-thérapeutique</b> comprend :</div><ul><li>NFS, Na<sup>+</sup>, créat, bilan hépato-rénal, uricémie</li><li>séro VIH, VHB, VHC</li><li>examen ophtalmo + vision couleurs (rifampicine)</li><li>recherche grossesse (pyrazinamide)</li></ul></div></div></div></foreignObject><text x="105" y="2399" fill="#000000" font-family="Karla" font-size="12px">Le bilan pré-thérapeutique comprend :...</text></switch></g><rect x="20" y="1190" width="760" height="500" fill="none" stroke="#000000" pointer-events="all"/><rect x="20" y="120" width="760" height="950" fill="none" stroke="#000000" pointer-events="all"/><rect x="0" y="100" width="80" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 115px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Introduction</div></div></div></foreignObject><text x="40" y="119" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">Introduction</text></switch></g><rect x="90" y="140" width="690" height="250" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 708px; height: 1px; padding-top: 132px; margin-left: 72px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>maladie transmissible liée à <b>Mycobacterium tuberculosis</b> (= BK), parfois M. bovis ou M. africanum<br /></li><li><b>BAAR aérobie stricte</b> à croissance lente et à multiplication intra- et extra-cellulaire</li><li>Localisation <b>pulmonaire </b>dans 75%</li><li>chez l'imD : 50% localisations extra-pulmonaires, 25% disséminé, symptômes plus légers</li><li>France </li><ul><li>faible incidence : 7/100 000/an</li><li>surtout IDF, Mayotte, Guyane, migrants d'Afrique subsaharienne, SDF</li><li>ALD pour 2 ans</li></ul><li>Monde</li><ul><li>10M cas/an avec 1.5M décès/an</li><li>F5 décès par maladie, F2 décès par maladie infectieuse<br /></li><li>6% sont des tuberculoses multi-résistantes (surtout ex-URSS, Chine, Inde)</li></ul><li><span style="font-size: 12px">Le traitement cible 3 <b>populations de BK</b> :</span></li><ul><li><span style="font-size: 12px">extra-cellulaires (95%) : contagiosité et symptômes ; ssb INH, RMP et streptomycine</span></li><li><span style="font-size: 12px">intra-cellulaires quiescents ; ssb PZA et RMP</span></li><li><span style="font-size: 12px">extra-cellulaires dans le caséeum : rechute ; ssb RMP</span></li></ul></ul></div></div></div></foreignObject><text x="72" y="144" fill="black" font-family="Karla" font-size="12px">maladie transmissible liée à Mycobacterium tuberculosis (= BK), parfois M. bovis ou M. africanum...</text></switch></g><rect x="20" y="140" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 150px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">généralités</div></div></div></foreignObject><text x="55" y="154" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">généralités</text></switch></g><rect x="90" y="390" width="690" height="230" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 708px; height: 1px; padding-top: 382px; margin-left: 72px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ol><li style="font-size: 12px"><b>Contamination </b>: inhalation d'aérosols (gouttelettes de toux) atteignant les alvéoles (= <b style="font-size: 12px">foyer primaire</b>)</li><li style="font-size: 12px"><span style="font-size: 12px"><b>Primo-infection</b> (= PIT) souvent asymptomatique (= ITL = infection tuberculeuse latente)</span></li><ul style="font-size: 12px"><li style="font-size: 12px">BK phagocytés puis multipliés dans <b style="font-size: 12px">macrophages </b>alvéolaires puis gagnent le gg hilaire. Le <b>complexe primaire</b> <br style="font-size: 12px" />est l'association foyer primaire + adénopathie, pouvant rester visible en RXT pendant des années</li><li style="font-size: 12px">Dans les semaines qui suivent la PIT : <b>réponse immune</b> avec afflux des monocytes épithélioïdes formant les <b>granulomes </b>giganto-cellulaires avec nécrose caséeuse contenant des bacilles quiescents. </li><li style="font-size: 12px">L'ITL est parfois patente avec AEG, érythème noueux, kérato-conjonctivite phlycténulaire, adn cervicales. </li></ul><li><span style="font-size: 12px"><b>Tuberculose maladie</b> (= TM) : multiplication des BK (pendant ou après ITL)</span></li><ul><li><span style="font-size: 12px">5% des ITL font une TM &lt; 2 ans post-PIT, 5% font une TM &gt; 2 ans post-PIT</span></li><li>fris de TM :</li><ul><li>imD, diabète, InRé</li><li>fragilité : imD, âges extrêmes, malnutrition, précarité</li><li>alcool, tabac, toxicomanie</li></ul></ul></ol><div><span style="color: rgba(0 , 0 , 0 , 0) ; font-family: monospace ; font-size: 0px">%3CmxGraphModel%3E%3Croot%3E%3CmxCell%20id%3D%220%22%2F%3E%3CmxCell%20id%3D%221%22%20parent%3D%220%22%2F%3E%3CmxCell%20id%3D%222%22%20value%3D%22%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3B3%26amp%3Bnbsp%3Bpopulations%26amp%3Bnbsp%3Bde%20BK%20sont%20%C3%A0%20cibler%20%3A%26lt%3Bbr%26gt%3B%26lt%3B%2Ffont%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bextra-cellulaires%20(95%25)%20%3A%20contagiosit%C3%A9%20et%20sympt%C3%B4mes%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20INH%2C%20RMP%20et%20streptomycine%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bintra-cellulaires%20quiescents%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bspan%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20PZA%20et%20RMP%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fspan%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3B%26lt%3Bspan%26gt%3Bextra-cellulaires%20dans%20le%20cas%C3%A9eum%20%3A%20rechute%26lt%3B%2Fspan%26gt%3B%26lt%3Bbr%26gt%3B%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Bfont-family%3A%20%26amp%3B%2334%3Bkarla%26amp%3B%2334%3B%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20RMP%26lt%3B%2Fspan%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3B%2Ful%26gt%3B%22%20style%3D%22text%3Bhtml%3D1%3B%22%20vertex%3D%221%22%20parent%3D%221%22%3E%3CmxGeometry%20x%3D%22120%22%20y%3D%22560%22%20width%3D%22430%22%20height%3D%22120%22%20as%3D%22geometry%22%2F%3E%3C%2FmxCell%3E%3C%2Froot%3E%3C%2FmxGraphModel%3E</span><br /></div></div></div></div></foreignObject><text x="72" y="394" fill="#000000" font-family="Karla" font-size="12px">Contamination : inhalation d'aérosols (gouttelettes de toux) atteignant les alvéoles (= foyer primaire)Primo-infection...</text></switch></g><rect x="20" y="390" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 405px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">histoire naturelle</div></div></div></foreignObject><text x="55" y="409" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">histoire na...</text></switch></g><rect x="100" y="0" width="600" height="80" fill="none" stroke="#000000" transform="translate(2,3)" opacity="0.25"/><rect x="100" y="0" width="600" height="80" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 598px; height: 1px; padding-top: 40px; margin-left: 101px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><font style="font-size: 30px">155 - Tuberculose</font></div></div></div></foreignObject><text x="400" y="44" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">155 - Tuberculose</text></switch></g><rect x="90" y="1210" width="690" height="70" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 1202px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>signes cliniques évoluant depuis des semaines ou des mois</li><li>RXT : nodules, infiltrats ou cavités des lobes supérieurs et postérieurs</li><li>contexte évocateur : contage, voyage, CSP, imD</li><li>dès la suspicion, isoler le patient jusqu'à 15 jours de ttt</li></ul></div></div></div></foreignObject><text x="77" y="1214" fill="black" font-family="Karla" font-size="12px">signes cliniques évoluant depuis des semaines ou des moisRXT : nodules, infiltrats ou cavités des lobes supérieurs et...</text></switch></g><rect x="20" y="1210" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1220px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">suspicion</div></div></div></foreignObject><text x="55" y="1224" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">suspicion</text></switch></g><rect x="20" y="1300" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1315px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">diagnostic<br />positif</div></div></div></foreignObject><text x="55" y="1319" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">diagnostic...</text></switch></g><rect x="88" y="1300" width="690" height="240" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 683px; height: 1px; padding-top: 1307px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><font><b>3 prélèvements</b> en 24h :<br /><ul><li><font><b>ECBC </b>en mycobactériologie (recherche de BAAR)</font></li><ul><li><font>si le patient ne crache pas, <b>tubage gastrique</b> le matin à jeun avant le lever</font></li></ul><li>si échec (3 prélèvements négatifs)</li><ul><li>fibroscopie bronchique avec aspiration dirigée <b style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">± </b><span style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">LBA</span></li></ul><li><span style="font-size: 12px">si miliaire</span></li><ul><li><span style="font-size: 12px">fibroscopie bronchique avec aspiration dirigée </span><b style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">± </b><span style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">LBA</span></li><li><font color="#202122"><span style="font-size: 12px">hémoc sur milieu isolator</span></font></li><li><font color="#202122"><span style="font-size: 12px">ECBU en mycobactériologie</span></font></li><li><font color="#202122"><span style="font-size: 12px">si leuco-neutropénie : myéloculture</span></font></li></ul><li><span style="color: rgb(32 , 33 , 34)">si extra-pulmonaire :</span><br /></li><ul><li><span style="color: rgb(32 , 33 , 34)">ganglionnaire : ponction ou biopsie-exérèse d'adénopathie accessible</span></li><li><span style="color: rgb(32 , 33 , 34)">neuro-méningée : PL</span></li><li><span style="color: rgb(32 , 33 , 34)">génito-urinaire : ECBU 3 jours de suite</span></li></ul></ul></font></div></div></div></foreignObject><text x="95" y="1319" fill="#000000" font-family="Karla" font-size="12px">3 prélèvements en 24h :...</text></switch></g><rect x="20" y="1540" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1550px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">analyse</div></div></div></foreignObject><text x="55" y="1554" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">analyse</text></switch></g><rect x="90" y="1540" width="690" height="150" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 1532px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>examen direct : recherche BAAR (coloration Ziehl-Neelsen) en qq heures ; positive ssi &gt; 10<sup>3</sup><span> bacilles/mL. Répéter les prélèvements si examen direct négatif (n'élimine pas le diagnostic)</span></li><li><span>anapath : granulome épithélioïde gigantocellulaire avec nécrose caséeuse (très évocateur mais non pathognomonique)</span></li><li>culture sur milieux enrichis</li><ul><li>milieu solide (Löwenstein-Jensen) en 3-4 semaines</li><li>milieu liquide en 10-15 jours mais doit être reconfirmé par examen direct</li></ul><li><span style="font-size: 12px">identification (M. tuberculosis ou atypique) par biochimie, culture ou PCR</span></li><li>ATBg obligatoire (2% de MDR : résistent à RMP et INH)</li></ul></div></div></div></foreignObject><text x="77" y="1544" fill="black" font-family="Karla" font-size="12px">examen direct : recherche BAAR (coloration Ziehl-Neelsen) en qq heures ; positive ssi &gt; 103 bacilles/mL. Répéter les...</text></switch></g><rect x="0" y="1170" width="80" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 1185px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Diagnostic</div></div></div></foreignObject><text x="40" y="1189" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">Diagnostic</text></switch></g><rect x="20" y="620" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 635px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">localisations</div></div></div></foreignObject><text x="60" y="639" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">localisations</text></switch></g><rect x="100" y="620" width="680" height="350" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 627px; margin-left: 107px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Les formes <b>pulmonaires </b>représentent <b>75%</b> des cas<br /><ul><li><b>Tuberculose pulmonaire commune</b> (la plus classique)</li><ul><li>pas de st spécifique : signes généraux, respiratoires (voire pleural)</li><li>lésions des segments postérieurs des lobes supérieurs (PO2 plus élevée : BK aérobie strict)</li><li>3 types de lésions pouvant s'associer : nodules, infiltrats et cavernes</li></ul><li><span style="font-size: 12px"><b>Miliaire </b>tuberculeuse</span></li><ul><li><span style="font-size: 12px">forme disséminée, généralisée, évolution svt défavorable : doit être pec rapidement</span></li><li><span style="font-size: 12px">PID micronodulaire en "grains de mil" bilatérale (parfois lésions macro-nodulaires si forme évoluée)</span></li></ul><li><span style="font-size: 12px"><b>Pleurésie </b>tuberculeuse</span></li><ul><li>épanchement exsudatif et lymphocytaire, unilatéral</li><li>examen direct positif dans &lt; 10%, culture (liquide ou biopsie) positive dans &lt; 30%, anapath de biopsies pleurales positives dans &gt; 80%</li></ul><li><span style="font-size: 12px"><b>Pneumonie aigüe</b> tuberculeuse</span></li><ul><li><span style="font-size: 12px">forme aigüe rare : ensemencement massif de BK sur lésion excavée avec inflammation intense</span></li><li><span style="font-size: 12px">RXT : comme PAC avec petites excavations</span></li></ul></ul><div>Les formes <b>extra-pulmonaires</b> représentent <b>25%</b> des cas, peuvent toucher tous les organes, mais surtout :</div><div><ul><li>gg (50% des formes extra-pulmonaires) : surtout cervicale et médiastinale</li><li>ostéo-articulaire : surtout spondylodiscite tuberculeuse (= mal de Pott)</li><li>génito-urinaire</li><li>neuro-méningée</li></ul></div></div></div></div></foreignObject><text x="107" y="639" fill="#000000" font-family="Karla" font-size="12px">Les formes pulmonaires représentent 75% des cas...</text></switch></g><rect x="20" y="970" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 985px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">vaccin</div></div></div></foreignObject><text x="60" y="989" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">vaccin</text></switch></g><rect x="100" y="970" width="680" height="80" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 693px; height: 1px; padding-top: 962px; margin-left: 87px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>Le vaccin n'est plus obligatoire depuis 2007, mais conseillé pour les enfants à haut risque</li><li>Administration le plus tôt possible</li><li>Pas de test tuberculinique préalable si nourrisson &lt; 3 mois, mais nécessaire jusqu'à 15 ans</li><li>CI si suspicion VIH ou imD (risque <b>BCGite disséminée</b> potentiellement létale)</li></ul></div></div></div></foreignObject><text x="87" y="974" fill="#000000" font-family="Karla" font-size="12px">Le vaccin n'est plus obligatoire depuis 2007, mais conseillé pour les enfants à haut risqueAdministration le plus tô...</text></switch></g><rect x="20" y="2380" width="78" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 76px; height: 1px; padding-top: 2395px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">bilans</div></div></div></foreignObject><text x="59" y="2399" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">bilans</text></switch></g><rect x="20" y="2848" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 2863px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">traitement</div></div></div></foreignObject><text x="55" y="2867" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">traitement</text></switch></g><rect x="88" y="2848" width="680" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 2855px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">En général 6 mois : <b>quadrithérapie 2 mois</b> puis <b>bithérapie 4 mois<br /></b></div></div></div></foreignObject><text x="95" y="2867" fill="#000000" font-family="Karla" font-size="12px">En général 6 mois : quadrithérapie 2 mois puis bithérapie 4 mois&#xa;</text></switch></g><rect x="20" y="2530" width="88" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 86px; height: 1px; padding-top: 2540px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">médicaments</div></div></div></foreignObject><text x="64" y="2544" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">médicaments</text></switch></g><rect x="0" y="2340" width="60" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 2355px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">TM</div></div></div></foreignObject><text x="30" y="2359" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">TM</text></switch></g><path d="M 218 2878 L 215.5 2878 Q 213 2878 213 2888 L 213 2895.5 Q 213 2903 210.5 2903 L 209.25 2903 Q 208 2903 210.5 2903 L 211.75 2903 Q 213 2903 213 2913 L 213 2920.5 Q 213 2928 215.5 2928 L 218 2928" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 268 2878 L 265.5 2878 Q 263 2878 263 2888 L 263 2895.5 Q 263 2903 260.5 2903 L 259.25 2903 Q 258 2903 260.5 2903 L 261.75 2903 Q 263 2903 263 2913 L 263 2920.5 Q 263 2928 265.5 2928 L 268 2928" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,263,2903)" pointer-events="all"/><rect x="218" y="2878" width="40" height="50" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2903px; margin-left: 219px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br />PZA<br />EMB</div></div></div></foreignObject><text x="238" y="2907" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><rect x="361" y="2878" width="40" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2893px; margin-left: 362px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br /></div></div></div></foreignObject><text x="381" y="2897" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 411 2878 L 408.5 2878 Q 406 2878 406 2885.5 L 406 2889.25 Q 406 2893 403.5 2893 L 402.25 2893 Q 401 2893 403.5 2893 L 404.75 2893 Q 406 2893 406 2900.5 L 406 2904.25 Q 406 2908 408.5 2908 L 411 2908" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,406,2893)" pointer-events="all"/><path d="M 361 2878 L 358.5 2878 Q 356 2878 356 2885.5 L 356 2889.25 Q 356 2893 353.5 2893 L 352.25 2893 Q 351 2893 353.5 2893 L 354.75 2893 Q 356 2893 356 2900.5 L 356 2904.25 Q 356 2908 358.5 2908 L 361 2908" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="88" y="2958" width="680" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 2965px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Si CI PZA : <b>trithérapie 3 mois </b>puis <b>bithérapie 6 mois</b></div></div></div></foreignObject><text x="95" y="2977" fill="#000000" font-family="Karla" font-size="12px">Si CI PZA : trithérapie 3 mois puis bithérapie 6 mois</text></switch></g><rect x="158" y="2988" width="40" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 3008px; margin-left: 159px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br />EMB</div></div></div></foreignObject><text x="178" y="3012" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 158 2988 L 155.5 2988 Q 153 2988 153 2998 L 153 3003 Q 153 3008 150.5 3008 L 149.25 3008 Q 148 3008 150.5 3008 L 151.75 3008 Q 153 3008 153 3018 L 153 3023 Q 153 3028 155.5 3028 L 158 3028" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 208 2988 L 205.5 2988 Q 203 2988 203 2998 L 203 3003 Q 203 3008 200.5 3008 L 199.25 3008 Q 198 3008 200.5 3008 L 201.75 3008 Q 203 3008 203 3018 L 203 3023 Q 203 3028 205.5 3028 L 208 3028" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,203,3008)" pointer-events="all"/><rect x="288" y="2988" width="40" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 3003px; margin-left: 289px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br /></div></div></div></foreignObject><text x="308" y="3007" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 288 2988 L 285.5 2988 Q 283 2988 283 2995.5 L 283 2999.25 Q 283 3003 280.5 3003 L 279.25 3003 Q 278 3003 280.5 3003 L 281.75 3003 Q 283 3003 283 3010.5 L 283 3014.25 Q 283 3018 285.5 3018 L 288 3018" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 338 2988 L 335.5 2988 Q 333 2988 333 2995.5 L 333 2999.25 Q 333 3003 330.5 3003 L 329.25 3003 Q 328 3003 330.5 3003 L 331.75 3003 Q 333 3003 333 3010.5 L 333 3014.25 Q 333 3018 335.5 3018 L 338 3018" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,333,3003)" pointer-events="all"/><path d="M 648 2968 L 648 2968.36 L 658 2968.48 L 668 2968.34 L 678 2967.28 L 688 2968.49 L 698 2968.74 L 708 2967.73 L 718 2968.29 L 728 2967.61 L 738 2968.38 L 748 2968.32 L 758 2968 L 758.22 2968 L 758.19 2976 L 757.81 2984 L 758.19 2992 L 757.94 3000 L 758 3008 L 758 3007.74 L 748 3008.49 L 738 3007.79 L 728 3008.74 L 718 3007.86 L 708 3007.55 L 698 3007.89 L 688 3008.57 L 678 3007.51 L 668 3008.58 L 658 3007.8 L 648 3008 L 647.9 3008 L 648.19 3000 L 647.9 2992 L 648.14 2984 L 648.17 2976 L 648 2968 L 648 2968 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2988px; margin-left: 649px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Les ATB sont à adapter selon l'ATBg</div></div></div></foreignObject><text x="703" y="2992" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">Les ATB sont à ada...</text></switch></g><rect x="108" y="2530" width="670" height="290" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 663px; height: 1px; padding-top: 2537px; margin-left: 115px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Les anti-tuberculeux utilisés en <b>1e intention</b> sont :</div><ul><li><b>Isoniazide </b>= INH (RIMIFON)</li><ul><li>EI : <b>hépatite</b>, nausées, polynévrite sst-mot si carence B6, rarement tb neuro-psy, réactions cutanées ou algodystrophies (sd épaule-main)</li></ul><li><b>Rifampicine </b><span>= RMP (RIMACTAN, RIFADINE)</span><br /></li><ul><li><span>EI : </span><b>coloration en orange</b><span> des larmes, sperme et urines (normal), nausées, phénomènes immuno-allergiques (thrombopénie, hémolyse, InRéA)</span><br /></li><li>intéractions : anticoagulants oraux, pilule oestro-progestative (changer), inhibiteurs de protéase, CTC, digitaliques, peut augmenter l'hépatotoxicité de INH et PZA</li></ul><li><span style="font-size: 12px"><b>Pyrazinamine </b>= PZA (PIRILENE)</span></li><ul><li><span style="font-size: 12px">CI si InHep ou InRé, déconseillée si grossesse</span></li><li><span style="font-size: 12px">EI : cytolise hépatique (plus tardif que INH), hyperuricémie svt ast, rash vasomoteur, nausées</span></li></ul><li><span style="font-size: 12px"><b>Ethambutol</b> = EMB (MYAMBUTOL, DEXAMBUTOL)</span></li><ul><li><span style="font-size: 12px">EI : névrite optique rétrobulbaire (fris : posologie élevée, éthylisme chronique, InRé) nécessitant une cs ophtalmo tous les mois pendant le traitement</span></li></ul></ul><div>En <b>2e intention</b>, on peut utiliser des <b>aminosides </b>(streptomycine et amikacine). Les EI principaux sont les toxicités rénale et auditive. Les <b>FQ </b>sont aussi utilisables en 2e intention</div></div></div></div></foreignObject><text x="115" y="2549" fill="black" font-family="Karla" font-size="12px">Les anti-tuberculeux utilisés en 1e intention sont :...</text></switch></g><path d="M 428 2500 L 428 2380" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 648 2848 L 648 2848.65 L 658 2847.34 L 668 2847.93 L 678 2847.93 L 688 2847.76 L 698 2847.4 L 708 2847.33 L 718 2847.78 L 728 2848.1 L 738 2848.54 L 748 2848.18 L 758 2848 L 757.65 2848 L 757.26 2858 L 758.22 2868 L 758.01 2878 L 757.89 2888 L 758 2898 L 758 2898.03 L 748 2897.44 L 738 2897.71 L 728 2898.08 L 718 2898.67 L 708 2897.98 L 698 2898.12 L 688 2898.09 L 678 2897.74 L 668 2897.85 L 658 2897.57 L 648 2898 L 648.06 2898 L 648.7 2888 L 648.36 2878 L 647.57 2868 L 648.39 2858 L 648 2848 L 648 2848 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2873px; margin-left: 649px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">si neuro-méningée : durée de 9-12 mois</div></div></div></foreignObject><text x="703" y="2877" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">si neuro-méningée...</text></switch></g><path d="M 638 2908 L 638 2907.99 L 648 2908.73 L 658 2907.89 L 668 2907.7 L 678 2908.08 L 688 2908.3 L 698 2907.68 L 708 2908.61 L 718 2908.1 L 728 2907.99 L 738 2907.77 L 748 2907.65 L 758 2908 L 758.7 2908 L 757.97 2918 L 758.31 2928 L 758.02 2938 L 758.12 2948 L 758 2958 L 758 2958.61 L 748 2957.84 L 738 2958.6 L 728 2957.51 L 718 2957.44 L 708 2958.12 L 698 2957.55 L 688 2957.6 L 678 2957.43 L 668 2957.92 L 658 2958.3 L 648 2957.8 L 638 2958 L 637.37 2958 L 637.29 2948 L 637.8 2938 L 637.37 2928 L 638.55 2918 L 638 2908 L 638 2908 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 118px; height: 1px; padding-top: 2933px; margin-left: 639px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">si miliaire très sévère : ajout CTC</div></div></div></foreignObject><text x="698" y="2937" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">si miliaire très sév...</text></switch></g><rect x="90" y="1780" width="690" height="170" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 683px; height: 1px; padding-top: 1787px; margin-left: 97px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px">Les 2 moyens de dépister les ITL sont :</div><div style="font-size: 12px"><ul style="font-size: 12px"><li style="font-size: 12px"><b style="font-size: 12px">IDR </b>(= intradermoréaction) = RCT (= réaction cutanée tuberculinique) </li><ul style="font-size: 12px"><li style="font-size: 12px">interprétation difficile si vaccin BCG &lt; 10 ans car se positive avec M. bovis</li><li style="font-size: 12px">lecture à 72h : IDR positive si induration &gt; 5 mm</li><li style="font-size: 12px">suspicion ITL si <b style="font-size: 12px">&gt; 10 mm sans BCG</b> ou augmentation<b style="font-size: 12px"> 10 mm entre 2 IDR en 3 mois</b></li></ul><li style="font-size: 12px"><b style="font-size: 12px">IGRA </b>(détection de production d'<span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">IFN</span><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">-</span><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">γ) par prise de sang</span></li><ul style="font-size: 12px"><li style="font-size: 12px"><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">meilleure VPP que l'IDR (osef BCG)</span></li><li style="font-size: 12px"><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">résultats après qq jours</span></li></ul></ul></div></div></div></div></foreignObject><text x="97" y="1799" fill="black" font-family="Karla" font-size="12px">Les 2 moyens de dépister les ITL sont :...</text></switch></g><path d="M 598 1210 L 598 1210.45 L 608 1210.63 L 618 1209.74 L 628 1210.47 L 638 1210.59 L 648 1210.41 L 658 1209.34 L 668 1210.04 L 678 1210.4 L 688 1210.71 L 698 1209.34 L 708 1209.61 L 718 1210.48 L 728 1209.49 L 738 1209.37 L 748 1209.6 L 758 1210 L 757.8 1210 L 757.49 1220 L 757.44 1230 L 758.48 1240 L 758.19 1250 L 758.04 1260 L 758 1270 L 758 1270.49 L 748 1269.51 L 738 1269.94 L 728 1270.63 L 718 1269.81 L 708 1269.86 L 698 1269.72 L 688 1269.41 L 678 1269.98 L 668 1270.37 L 658 1269.6 L 648 1269.49 L 638 1270.22 L 628 1269.67 L 618 1270.46 L 608 1270.41 L 598 1270 L 597.35 1270 L 598.62 1260 L 598.32 1250 L 597.8 1240 L 598.66 1230 L 598.7 1220 L 598 1210 L 598 1210 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 158px; height: 1px; padding-top: 1240px; margin-left: 600px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"><span>Déclaration ARS :</span></div>- ITL d'enfant &lt; 15 ans<br />- TM confirmée ou suspectée</div></div></div></foreignObject><text x="600" y="1244" fill="#000000" font-family="Pangolin" font-size="12px">Déclaration ARS :- ITL d'e...</text></switch></g><rect x="0" y="1740" width="60" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 1755px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">ITL</div></div></div></foreignObject><text x="30" y="1759" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ITL</text></switch></g><rect x="20" y="1780" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1790px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">dépistage</div></div></div></foreignObject><text x="55" y="1794" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">dépistage</text></switch></g><rect x="228" y="1950" width="60" height="20" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 1960px; margin-left: 229px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">contact</div></div></div></foreignObject><text x="258" y="1964" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">contact</text></switch></g><path d="M 243 1970 L 210.64 1987.03" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 205.99 1989.48 L 210.55 1983.12 L 210.64 1987.03 L 213.81 1989.32 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 273 1970 L 294.88 1986.21" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 299.1 1989.33 L 291.39 1987.98 L 294.88 1986.21 L 295.56 1982.36 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 180.02 2020 L 180.15 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 180.16 2138.88 L 176.65 2131.89 L 180.15 2133.63 L 183.65 2131.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="130" y="1990" width="100" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 98px; height: 1px; padding-top: 2005px; margin-left: 132px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">- enfant &lt; 2 ans<br />- imD sévère</div></div></div></foreignObject><text x="132" y="2009" fill="#000000" font-family="Karla" font-size="12px">- enfant &lt; 2 ans...</text></switch></g><rect x="130" y="2140" width="380" height="70" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe center; width: 378px; height: 1px; padding-top: 2147px; margin-left: 131px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">CHIMIOPROPHYLAXIE</div></div></div></foreignObject><text x="320" y="2159" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">CHIMIOPROPHYLAXIE</text></switch></g><rect x="280" y="1990" width="80" height="50" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 78px; height: 1px; padding-top: 2015px; margin-left: 282px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">- répété<br />- rapproché<br />- fragile</div></div></div></foreignObject><text x="282" y="2019" fill="#000000" font-family="Karla" font-size="12px">- répété...</text></switch></g><rect x="370" y="1975" width="190" height="60" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 188px; height: 1px; padding-top: 2005px; margin-left: 372px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"></div><font style="font-size: 12px">- avant ttt <span style="color: rgb(34 , 34 , 34) ; background-color: rgb(255 , 255 , 255) ; font-size: 12px">anti-TNFα<br /></span>- bilan VIH<br />- pro. santé<br />- migrants &lt; 15 ans forte endémie<br /></font></div></div></div></foreignObject><text x="372" y="2009" fill="#000000" font-family="Karla" font-size="12px">- avant ttt anti-TNFα...</text></switch></g><path d="M 320 2090 L 320 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 320 2138.88 L 316.5 2131.88 L 320 2133.63 L 323.5 2131.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="280" y="2060" width="80" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 2075px; margin-left: 281px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div><b>IDR ou IGRA</b><br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="320" y="2079" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">IDR ou IGRA&#xa;</text></switch></g><path d="M 320 2040 L 320 2053.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 320 2058.88 L 316.5 2051.88 L 320 2053.63 L 323.5 2051.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 465 2035 L 465 2058.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 465 2063.88 L 461.5 2056.88 L 465 2058.63 L 468.5 2056.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="340" y="2170" width="170" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 168px; height: 1px; padding-top: 2190px; margin-left: 341px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">bithérapie 3-4 mois<br /><div><span style="font-size: 14px ; font-weight: 400 ; background-color: rgb(255 , 255 , 255)">(INH + RMP)</span></div></div></div></div></foreignObject><text x="425" y="2194" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">bithérapie 3-4 mois...</text></switch></g><rect x="300" y="2170" width="40" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2180px; margin-left: 301px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; "><span style="font-weight: normal">ou</span></div></div></div></foreignObject><text x="320" y="2184" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">ou</text></switch></g><rect x="130" y="2170" width="170" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 168px; height: 1px; padding-top: 2190px; margin-left: 131px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">monothérapie 6-9 mois<br /><span style="font-weight: normal">(INH)</span></div></div></div></foreignObject><text x="215" y="2194" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">monothérapie 6-9 mois...</text></switch></g><rect x="125" y="2065" width="110" height="30" fill="#ffffff" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2080px; margin-left: 126px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">ne pas attendre la<br />confirmation d'ITL</div></div></div></foreignObject><text x="180" y="2084" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ne pas attendre la...</text></switch></g><path d="M 465.02 2085 L 465.14 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 465.16 2138.88 L 461.64 2131.89 L 465.14 2133.63 L 468.64 2131.87 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="445" y="2065" width="40" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2075px; margin-left: 446px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div><b>IGRA</b><br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="465" y="2079" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">IGRA&#xa;</text></switch></g><rect x="396" y="1950" width="100" height="20" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 98px; height: 1px; padding-top: 1960px; margin-left: 398px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"></div><font style="font-size: 12px"><b>autres situations</b><br /></font></div></div></div></foreignObject><text x="398" y="1964" fill="#000000" font-family="Karla" font-size="12px">autres situation...</text></switch></g><rect x="377" y="2100" width="210" height="20" fill="#ffffff" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 208px; height: 1px; padding-top: 2110px; margin-left: 378px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div>ssi &lt; 18 ans, imD ou ITL récent (&lt; 1 an)<br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="482" y="2114" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ssi &lt; 18 ans, imD ou ITL récent (&lt;...</text></switch></g><rect x="20" y="1950" width="50" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 48px; height: 1px; padding-top: 1960px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">CAT</div></div></div></foreignObject><text x="45" y="1964" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">CAT</text></switch></g><rect x="20" y="3060" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 3075px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">cas particuliers</div></div></div></foreignObject><text x="55" y="3079" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">cas particu...</text></switch></g><rect x="90" y="3060" width="690" height="210" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 3052px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>grossesse</li><ul><li>supplémenter en B6 (INH), K1 (RMP)</li><li>en France, PZA déconseillée pendant grossesse et allaitement</li></ul><li>InRé</li><ul><li>clairance &gt; 30 : ttt normal</li><li>clairance = 15-30 : diminuer EMB, PZA</li><li>clairance &lt; 15 ou dialyse : diminuer INH, EMB, PZA</li></ul><li><span style="font-size: 12px">InHep</span></li><ul><li><span style="font-size: 12px">transaminases = 3-6N asymptomatique : arrêt PZA (peut être repris si retour à la normale)</span></li><li><span style="font-size: 12px">transaminases &gt; 6N ou symptomatique : arrêt INH et PZA voire du ttt antituberculeux</span></li></ul><li><span style="font-size: 12px">tuberculoses multi-résistantes</span></li><ul><li><span style="font-size: 12px">MDR (VS INH et RMP) : représente 2% des tuberculoses en France, ttt de 2e intention (aminosides, FQ)</span></li><li><span style="font-size: 12px">XDR (MDR + FQ + ...) : très mortelle mais exceptionnelle en France</span></li></ul></ul></div></div></div></foreignObject><text x="77" y="3064" fill="#000000" font-family="Karla" font-size="12px">grossesse...</text></switch></g><path d="M 603 1310 L 603 1309.8 L 613 1310.53 L 623 1309.72 L 633 1309.48 L 643 1310.26 L 653 1310.67 L 663 1309.69 L 673 1309.88 L 683 1310.52 L 693 1310.3 L 703 1310.46 L 713 1309.8 L 723 1309.92 L 733 1310.42 L 743 1309.79 L 753 1310 L 752.28 1310 L 753.44 1320 L 753.17 1330 L 752.67 1340 L 752.8 1350 L 753 1360 L 753 1360.52 L 743 1359.56 L 733 1359.43 L 723 1360.55 L 713 1360.2 L 703 1359.9 L 693 1359.83 L 683 1360.65 L 673 1359.73 L 663 1359.73 L 653 1359.32 L 643 1360.35 L 633 1359.87 L 623 1360.45 L 613 1359.86 L 603 1360 L 603.7 1360 L 602.96 1350 L 602.82 1340 L 603.48 1330 L 602.96 1320 L 603 1310 L 603 1310 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 148px; height: 1px; padding-top: 1335px; margin-left: 605px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Déclaration CLAT nominatif pour enquête autour du cas<br /><div style="text-align: center"></div></div></div></div></foreignObject><text x="605" y="1339" fill="#000000" font-family="Pangolin" font-size="12px">Déclaration CLAT nominati...</text></switch></g><rect x="668" y="1280" width="20" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 18px; height: 1px; padding-top: 1290px; margin-left: 669px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 19px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">+</div></div></div></foreignObject><text x="678" y="1296" fill="#000000" font-family="Pangolin" font-size="19px" text-anchor="middle">+</text></switch></g></g><switch><g requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"/><a transform="translate(0,-5)" xlink:href="https://desk.draw.io/support/solutions/articles/16000042487" target="_blank"><text text-anchor="middle" font-size="10px" x="50%" y="100%">Viewer does not support full SVG 1.1</text></a></switch></svg>